Mitochondrial dysfunction, oxidative stress and apoptotic induction in microglial BV-2 cells treated with sodium arsenate (cas 15120-17-9)

Add time:07/28/2019    Source:sciencedirect.com

The treatment of microglial BV-2 cells with sodium arsenate (As(V): 0.1–400 μmol/L — 48 hr) induces a dose-dependent response. The neurotoxic effects of high concentrations of As(V) (100, 200 and 400 μmol/L) are characterized by increased levels of mitochondrial complexes I, II, and IV followed by increased superoxide anion generation. Moreover, As(V) triggers an apoptotic mode of cell death, demonstrated by an apoptotic SubG1 peak, associated with an alteration of plasma membrane integrity. There is also a decrease in transmembrane mitochondrial potential and mitochondrial adenosine triphosphate ATP. It is therefore tempting to speculate that As(V) triggers mitochondrial dysfunction, which may lead to defective oxidative phosphorylation subsequently causing mitochondrial oxidative damage, which in turn induces an apoptotic mode of cell death.

We also recommend Trading Suppliers and Manufacturers of sodium arsenate (cas 15120-17-9). Pls Click Website Link as below: cas 15120-17-9 suppliers

Prev:Impact of prenatal arsenate exposure on gene expression in a pure population of migratory cranial neural crest cells
Next:The role of thymoquinone as a potent antioxidant in ameliorating the neurotoxic effect of sodium arsenate (cas 15120-17-9) in female rat)